Science at Abbott

Science at Abbott Laboratories Life and health are invaluable. That’s why Abbott is committed to addressing unmet medical needs for people around the world. In each of our businesses, we accomplish this goal by using breakthrough science and innovative technology to deliver products to improve lives in a wide variety of ways.

Abbott scientists are advancing the state of the art in:

  Diabetes   Pediatric Nutrition   Neuroscience
  Molecular Diagnostics   Cardiovascular (Dyslipidemia)   Oncology
  Adult Nutrition   Immunology   Pain Care

Science: Our Foundation

Abbott Laboratories Wins Prix Galien or Galen PrizeAbbott was founded on the idea that using new technologies and treatment approaches could dramatically improve the quality of care for patients. Throughout our history, Abbott’s commitment to scientific investigation has led to breakthrough innovations that have changed the practice of medicine. Abbott science and scientists have been honored with some of our industry's highest accolades. These include the Prix Galien, or Galen Prize, which is considered by industry to be equivalent to the Nobel Prize for pharmaceutical research and development. Today Abbott's dedication to cutting-edge science continues to drive innovation in our Pharmaceuticals, Medical Devices and Nutritionals businesses.

 

Abbott Scientists

We have a global network of more than 7,000 scientists working in:
Canada
Germany
Japan
Mexico
United States

Coast-to-Coast R&D

Our U.S.-based Research and Development efforts take place in a variety of locations.
Worcester, Massachusetts
Parsippany, New Jersey
Lake County, Illinois
Santa Clara, California
Austin, Texas
Columbus, Ohio

Abbott Innovation

HUMIRA (adalimumab): Treating Rheumatoid Arthritis & More HUMIRA (adalimumab), the first fully human anti-TNF monoclonal antibody approved for the treatment of adults with moderate to severe rheumatoid arthritis, moderate to severe Crohn's disease, ankylosing spondylitis (arthritis of the spine), psoriatic arthritis, moderate to severe chronic plaque psoriasis and juvenile idiopathic arthritis
Similac, an Extensive Line of Infant Formulas Similac, an extensive line of infant formulas based on decades of innovation
    
   
PathVysion to Test for HER-2 Gene

  

 PathVysion, a molecular test which detects amplified genes in breast cancer patients
   

Glucerna: Smart Nutrition for People with Diabetes		 Glucerna, clinically proven products with unique blends of slowly digestive carbohydrates to help minimize blood sugar spikes
Kaletra (lopinavir/ritonavir): Advancing the Fight Against HIV Kaletra® (lopinavir/ritonavir) and Norvir® (ritonavir), HIV protease inhibitors that improve patient treatment

 

For important product information, please access:


Printer Friendly Printer Friendly

Home | Select a Country | Site Map | Contact Us | Privacy Policy | Terms of Use

Copyright © 2006, 2008 Abbott Laboratories. Abbott Park, Illinois, U.S.A.


Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.